Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization

• DOI: 10.3389/fonc.2024.1433480
• Publication Date: 2024-08-07T04:48:58Z
• Authors: Bita Kalaghchi; Semra Ince; Justin Barnes; Kendall Kiser; Re-I Chin; Justin Mikell; Shahed Badiyan; Jose Garcia; Jacqueline Zoberi; Maria Bernadette ...; Benjamin Tan; Seung Kim; Tyler Fraum; Hyun Kim
• Keywords: Glass microsphere

Radioembolization with yttrium-90 (Y-90) is utilized to treat primary liver malignancies. The efficacy of this intra-arterial therapy in arterially hypoperfused tumors not known.